BFRI News and Press, Biofrontera Inc. From 07/03/23

2023-07-03 09:51:03 ET Biopharmaceutical company Biofrontera ( NASDAQ: BFRI ) said on Monday that it will effect a 1-for-20 reverse stock split from the close of trading at 11:59 PM today. Biofrontera will begin trading on Nasdaq on a split-adjusted basis from Wednesday, July ...

WOBURN, MA / ACCESSWIRE / July 3, 2023 / Biofrontera Inc. (Nasdaq:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, announces that it will effect a reverse stock split of its outstanding shares of common stock at a...

WOBURN, MA / ACCESSWIRE / June 12, 2023 / Biofrontera Inc. (Nasdaq:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, announces its sponsorship of The Sun Bus , a mobile classroom and clinic bringing free skin canc...

WOBURN, MA / ACCESSWIRE / June 1, 2023 / Biofrontera Inc. (Nasdaq:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, announces it has engaged a contract manufacturer to develop a new, low-cost portable photodynamic ...

WOBURN, MA / ACCESSWIRE / May 30, 2023 / Biofrontera Inc. (Nasdaq:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, announces that its Board of Directors has named Hermann Luebbert as Chief Executive Officer. Mr. L...

Novel Protocol is Expected to be Less Painful with Efficacy Similar to Conventional PDT WOBURN, MA / ACCESSWIRE / May 15, 2023 / Biofrontera Inc. (Nasdaq:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, announces that the U.S....

2023-05-12 12:33:09 ET Biofrontera Inc. (BFRI) Q1 2023 Earnings Conference Call May 12, 2023 08:30 ET Company Participants Tirth Patel - Investor Relations Hermann Luebbert - Executive Chairman and Founder Fred Leffler - Chief Financial Officer Conference C...

2023-05-12 08:59:59 ET Biofrontera press release ( NASDAQ: BFRI ): Q1 GAAP EPS of -$0.28. Revenue of $8.73M (-10.5% Y/Y). For further details see: Biofrontera GAAP EPS of -$0.28, revenue of $8.73M

2023-05-12 07:48:29 ET Biofrontera press release ( NASDAQ: BFRI ): Q1 GAAP EPS of -$0.28 misses by $0.08 . Revenue of $8.7M (-11.2% Y/Y) misses by $0.45M . Cash and cash equivalents were $13.5 million as of March 31, 2023, compared with $17.2 million on Decembe...

Conference call begins at 8:30 a.m. Eastern time today WOBURN, MA / ACCESSWIRE / May 12, 2023 / Biofrontera Inc. (Nasdaq:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, today reported financial results for the three months en...